Galera Therapeutics (GRTX) News Today → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free GRTX Stock Alerts $0.20 +0.01 (+5.40%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13, 2024 | globenewswire.comGalera Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesMay 3, 2024 | finanznachrichten.deGalera Therapeutics: Galera Adopts Limited Duration Stockholder Rights AgreementMay 3, 2024 | globenewswire.comGalera Adopts Limited Duration Stockholder Rights AgreementApril 1, 2024 | msn.comGalera Therapeutics Seeks Strategic Alternatives Amid Financial Setbacks and Regulatory ChallengesMarch 28, 2024 | finanznachrichten.deGalera Therapeutics: Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate UpdatesMarch 28, 2024 | globenewswire.comGalera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate UpdatesMarch 16, 2024 | finance.yahoo.comGRTX Apr 2024 0.500 callMarch 12, 2024 | nz.finance.yahoo.comGalera Therapeutics, Inc. (GRTX)February 27, 2024 | edition.cnn.comGalera Therapeutics, Inc.February 4, 2024 | investing.comGalera Therapeutics Inc (GRTX)February 4, 2024 | benzinga.comGalera Therapeutics Stock (NASDAQ:GRTX) Dividends: History, Yield and DatesJanuary 21, 2024 | finance.yahoo.comGalera Therapeutics Insiders Lose Out As Stock Sinks To US$0.17January 16, 2024 | bizjournals.comLocal publicly traded stocks lag far behind national indices in 2023January 9, 2024 | msn.comDow Tumbles Over 200 Points; US Trade Gap Narrows In NovemberNovember 28, 2023 | msn.comGalera Therapeutics (GRTX) Price Target Increased by 7.14% to 0.38November 14, 2023 | finanznachrichten.deGalera Therapeutics: Galera Reports Third Quarter 2023 Financial Results and Recent Corporate UpdatesNovember 14, 2023 | benzinga.comGalera Therapeutics: Q3 Earnings InsightsNovember 14, 2023 | finance.yahoo.comGalera Reports Third Quarter 2023 Financial Results and Recent Corporate UpdatesNovember 13, 2023 | benzinga.comGalera Therapeutics's Earnings OutlookNovember 1, 2023 | benzinga.comUS Stocks Fall; Pfizer Swings To Q3 LossOctober 31, 2023 | benzinga.comDow Gains 50 Points; Global Payments Posts Upbeat EarningsOctober 31, 2023 | bizjournals.comGalera Therapeutics warns of potential shutdown as it halts clinical trials and stock tanksOctober 31, 2023 | msn.comWhy Is Cancer Focused Galera Therapeutics Stock Sinking Today?October 31, 2023 | msn.comGalera plunges after citing risks to business continuityOctober 31, 2023 | finanznachrichten.deGalera Therapeutics: Galera Announces Receipt of Type A Meeting Minutes and Strategic UpdateOctober 31, 2023 | finance.yahoo.comGalera Announces Receipt of Type A Meeting Minutes and Strategic UpdateOctober 31, 2023 | marketbeat.comTrading was temporarily halted for "GRTX" at 06:10 AM with a stated reason of "News pending."September 19, 2023 | markets.businessinsider.comGalera Therapeutics (GRTX) Gets a Hold from H.C. WainwrightSeptember 18, 2023 | finance.yahoo.comGalera Schedules Type A Meeting with FDA to Discuss Next Steps for AvasopasemSeptember 5, 2023 | finance.yahoo.comGalera to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 30, 2023 | markets.businessinsider.comCiti Sticks to Its Hold Rating for Galera Therapeutics (GRTX)August 30, 2023 | nasdaq.comCitigroup Maintains Galera Therapeutics (GRTX) Neutral RecommendationAugust 29, 2023 | markets.businessinsider.comExpert Ratings for Galera TherapeuticsAugust 16, 2023 | markets.businessinsider.comH.C. Wainwright downgrades Galera Therapeutics (GRTX) to a HoldAugust 14, 2023 | finance.yahoo.comGalera Reports Second Quarter 2023 Financial Results and Recent Corporate UpdatesAugust 11, 2023 | msn.comGalera cut to Underperform at BofA after FDA snub for lead assetAugust 10, 2023 | msn.comWhy Is Galera Therapeutics Stock Sinking Today?August 10, 2023 | finance.yahoo.comGalera shares plunge 85% on FDA rejection; workforce cut by more than halfAugust 10, 2023 | finanznachrichten.deGalera Therapeutics: Galera Receives Complete Response Letter from U.S. FDA for Avasopasem ManganeseAugust 10, 2023 | markets.businessinsider.comGalera Gets CRL From FDA For Avasopasem Manganese, To Cut 70% Jobs; Stock Down In PremarketAugust 9, 2023 | msn.comFDA rejects Galera's treatment for mouth sores in cancer patients, stock -83% after hoursAugust 9, 2023 | finance.yahoo.comGalera Receives Complete Response Letter from U.S. FDA for Avasopasem ManganeseAugust 9, 2023 | finance.yahoo.comGalera shares tank after US FDA declines to approve inflammation disease drugAugust 9, 2023 | marketbeat.comTrading was temporarily halted for "GRTX" at 04:08 PM with a stated reason of "News pending."July 27, 2023 | uk.finance.yahoo.comGRTX - Galera Therapeutics, Inc.July 17, 2023 | bizjournals.comSt. Louis stocks have fallen behind major indices this yearJuly 17, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Galera Therapeutics (GRTX), Acumen Pharmaceuticals (ABOS)June 28, 2023 | finance.yahoo.comDespite Galera Therapeutics' Pullback, Insiders Still Gained US$102kJune 6, 2023 | markets.businessinsider.comPiper Sandler Remains a Buy on Galera Therapeutics (GRTX)June 5, 2023 | finance.yahoo.comGalera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meeting Get Galera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Gold Set to EXPLODE! (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! GRTX Media Mentions By Week GRTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRTX News Sentiment▼0.970.54▲Average Medical News Sentiment GRTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRTX Articles This Week▼31▲GRTX Articles Average Week Get Galera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: UPC News Today CMMB News Today MTEM News Today ATHE News Today NCNA News Today ADXN News Today AEZS News Today GHSI News Today MBRX News Today MIRA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRTX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.